Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to […]
